Spots Global Cancer Trial Database for treosulfan
Every month we try and update this database with for treosulfan cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Preference Study With Elderly Patients Recurrent Ovarian Cancer | NCT00170690 | Ovarian Cancer | Treosulfan Treosulfan | 70 Years - | North Eastern German Society of Gynaecological Oncology | |
| A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC | NCT02852083 | Squamous Cell L... Non-Squamous Ce... Non-Small Cell ... | Pioglitazone nivolumab Treosulfan Clarithromycin | 18 Years - | University Hospital Regensburg | |
| Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant | NCT03961919 | Acute Myeloid L... Myelodysplastic... Transplant-Rela... | Fludarabine ARA-C Treosulfan Peripheral Bloo... | 65 Years - | IRCCS San Raffaele | |
| Treosulfan-based Conditioning for Transplantation in AML/MDS | NCT00491634 | Acute Myeloid L... Myelodysplastic... | treosulfan Treosulfan | 18 Years - 68 Years | Sheba Medical Center | |
| Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients | NCT05636787 | Multiple Myelom... | Treosulfan Melphalan | 18 Years - 75 Years | Insel Gruppe AG, University Hospital Bern | |
| Study in Localized and Disseminated Ewing Sarcoma | NCT00987636 | Ewing's Sarcoma | Zoledronic acid Busulfan Treosulfan | 48 Months - 50 Years | University Hospital Muenster | |
| Study of Metastatic Ocular Melanoma | NCT00168870 | Ocular Melanoma | Gemcitabine Treosulfan | 18 Years - | Charite University, Berlin, Germany | |
| MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies | NCT00129155 | Hematological M... Allogeneic Tran... | treosulfan | 18 Years - 65 Years | Hospices Civils de Lyon | |
| Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT | NCT01772953 | Acute Myeloid L... Myelodysplastic... | Treosulfan | - 21 Years | Center for International Blood and Marrow Transplant Research | |
| Preference Study With Elderly Patients Recurrent Ovarian Cancer | NCT00170690 | Ovarian Cancer | Treosulfan Treosulfan | 70 Years - | North Eastern German Society of Gynaecological Oncology | |
| ALL SCTped FORUM - Pharmacogenomic Study (add-on Study) | NCT02670564 | Acute Lymphobla... | Pharmacogenomic... Busulfan plasma... | - 18 Years | Swiss Pediatric Oncology Group | |
| Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia | NCT04994808 | Acute Myeloid L... Myelodysplastic... | Clofarabine Fludarabine Hematopoietic C... Total-Body Irra... Treosulfan | 18 Years - 70 Years | Fred Hutchinson Cancer Center | |
| Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients | NCT05636787 | Multiple Myelom... | Treosulfan Melphalan | 18 Years - 75 Years | Insel Gruppe AG, University Hospital Bern | |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia | NCT01949129 | Acute Lymphobla... | VP16 TBI Thiotepa Treosulfan Fludarabine Busulfan ATG Thymoglobul... Cyclophosphamid... Grafalon | 1 Month - 18 Years | St. Anna Kinderkrebsforschung | |
| MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies | NCT00129155 | Hematological M... Allogeneic Tran... | treosulfan | 18 Years - 65 Years | Hospices Civils de Lyon | |
| Dose-range Finding Treosulfan-based Conditioning | NCT01063647 | Hematological M... | Treosulfan Treosulfan Treosulfan | 18 Years - | medac GmbH | |
| Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies | NCT01079013 | Non Hodgkin Lym... Hodgkin Lymphom... | treosulfan | 18 Years - 68 Years | Sheba Medical Center | |
| Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics | NCT05534620 | Acute Myeloid L... Myelodysplastic... Allogeneic Hema... | Treosulfan Fludarabine | 18 Years - 80 Years | medac GmbH | |
| Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) | NCT04965597 | Bone Marrow Fai... Congenital Ameg... Congenital Pure... Hereditary Side... Paroxysmal Noct... Shwachman-Diamo... Hematologic Neo... Hematologic Neo... Hematologic Neo... | Treosulfan Fludarabine Pho... Tacrolimus Methotrexate Lapine T-Lympho... Peripheral Bloo... Allogeneic Bone... Quality-of-Life... Echocardiograph... Multigated Acqu... Bone Marrow Bio... Bone Marrow Asp... Biospecimen Col... | 1 Year - 49 Years | Fred Hutchinson Cancer Center | |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia | NCT01949129 | Acute Lymphobla... | VP16 TBI Thiotepa Treosulfan Fludarabine Busulfan ATG Thymoglobul... Cyclophosphamid... Grafalon | 1 Month - 18 Years | St. Anna Kinderkrebsforschung | |
| Study in Localized and Disseminated Ewing Sarcoma | NCT00987636 | Ewing's Sarcoma | Zoledronic acid Busulfan Treosulfan | 48 Months - 50 Years | University Hospital Muenster | |
| Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML) | NCT01063660 | Acute Myeloid L... | Treosulfan | 18 Years - 60 Years | medac GmbH | |
| T&B Depletion Non Malignant | NCT01810926 | Graft Versus Ho... | polyclonal anti... Rituximab Treosulfan Fludarabine Thiotepa Cyclosporine A Methotrexate Methotrexate | 28 Days - 64 Years | Bambino Gesù Hospital and Research Institute | |
| Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies | NCT02333058 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... Juvenile Myelom... | Treosulfan | 28 Days - 17 Years | medac GmbH | |
| Treosulfan-based Conditioning for Transplantation in AML/MDS | NCT00491634 | Acute Myeloid L... Myelodysplastic... | treosulfan Treosulfan | 18 Years - 68 Years | Sheba Medical Center | |
| Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant | NCT03961919 | Acute Myeloid L... Myelodysplastic... Transplant-Rela... | Fludarabine ARA-C Treosulfan Peripheral Bloo... | 65 Years - | IRCCS San Raffaele | |
| Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia | NCT00860574 | Accelerated Pha... Adult Acute Lym... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Blastic Phase C... Childhood Acute... Childhood Acute... Childhood Chron... Childhood Myelo... Chronic Myelomo... de Novo Myelody... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Secondary Myelo... Untreated Adult... Untreated Child... | treosulfan fludarabine pho... total-body irra... peripheral bloo... tacrolimus allogeneic bone... allogeneic hema... methotrexate | - 60 Years | Fred Hutchinson Cancer Center | |
| Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies | NCT02333058 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... Juvenile Myelom... | Treosulfan | 28 Days - 17 Years | medac GmbH | |
| Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies | NCT01079013 | Non Hodgkin Lym... Hodgkin Lymphom... | treosulfan | 18 Years - 68 Years | Sheba Medical Center | |
| A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC | NCT02852083 | Squamous Cell L... Non-Squamous Ce... Non-Small Cell ... | Pioglitazone nivolumab Treosulfan Clarithromycin | 18 Years - | University Hospital Regensburg | |
| Study of Metastatic Ocular Melanoma | NCT00168870 | Ocular Melanoma | Gemcitabine Treosulfan | 18 Years - | Charite University, Berlin, Germany |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
